Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

ASP Isotopes (ASPI) Shares Outstanding (2022 - 2025)

ASP Isotopes has reported Shares Outstanding over the past 4 years, most recently at $111.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 54.96% year-over-year to $111.7 million; the TTM value through Dec 2025 reached $111.7 million, up 54.96%, while the annual FY2025 figure was $111.7 million, 54.96% up from the prior year.
  • Shares Outstanding for Q4 2025 was $111.7 million at ASP Isotopes, up from $83.9 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $111.7 million in Q4 2025 and troughed at $29.4 million in Q2 2022.
  • A 4-year average of $55.2 million and a median of $48.6 million in 2024 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: rose 27.13% in 2023 and later skyrocketed 78.39% in 2024.
  • Year by year, Shares Outstanding stood at $35.9 million in 2022, then grew by 6.8% to $38.3 million in 2023, then surged by 87.93% to $72.1 million in 2024, then skyrocketed by 54.96% to $111.7 million in 2025.
  • Business Quant data shows Shares Outstanding for ASPI at $111.7 million in Q4 2025, $83.9 million in Q2 2025, and $72.1 million in Q1 2025.